Lv31
388 积分 2024-04-17 加入
Drug development risk and the cost of capital
2小时前
已完结
Dual Inhibition of Interleukin-23 and Interleukin-17 Offers Superior Efficacy in Mouse Models of Autoimmunity
6天前
已完结
TNF-like ligand 1A is associated with the pathogenesis of psoriasis vulgaris and contributes to IL-17 production in PBMCs
9天前
已完结
The Entrepreneur's Guide Through the Galaxy of Biotech Funding
11天前
已完结
Biopharmaceutical Innovation at a Glance
11天前
已完结
Pharmaceutical Business Development and Licensing – Overview of a Cross‐Functional and Multifaceted Role and Its Key Elements in Biopharmaceutical Industry
11天前
已完结
Top companies and drugs by sales in 2023
25天前
已完结
Biomarker-Driven Oncology Clinical Trials: Key Design Elements, Types, Features, and Practical Considerations
25天前
已关闭
Biomarkers as drug development tools: discovery, validation, qualification and use
25天前
已完结
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
1个月前
已完结
皖公网安备34019202002308
